title: [Remodeling of microtubule system during EGF receptor endocytosis].
abstract: The idea of microtubules (MTs) as of passive railway tracks, along which transport vesicles travel by use of motor proteins, is widely accepted. In the present work the organization of MT system during EGF-receptor endocytosis was investigated by indirect double immunofluorescence in HeLa and A431 cell lines. Stimulation of cells with EGF resulted in formation of EGF receptor-containing peripheral vesicular endosomes. During time course of endocytosis the endosomes tended to concentrate in juxtranuclear region close to MTOC. This translocation was dependent on MTs since nocodazole treatment resulted in endosomes' scattering throughout the cytoplasm. Parallel staining of the cells with tubulin antibody has revealed significant remodeling of MTs organization during endocytosis. At early stages MTs demonstrated slight retraction at the cell periphery and the increasing intensity of tubulin fluorescence in the juxtranuclear region. Later on, long individual MTs disappeared and peripheral cytoplasm show diffuse staining in combination with a meshwork of short MT fragments. This stage correlated with EGFR localization in juxtranuclear endosomes. Disappearance of EGFR-positive staining due to its lysosomal degradation occurred in parallel to reestablishment of radial MT system. Possible functional significance of described alterations in organization of tubulin cytoskeleton is discussed.
authors.forename: M V
authors.initials: MV
authors.lastname: Kharchenko
authors.forename: E S
authors.initials: ES
authors.lastname: Kornilova
authors.forename: M S
authors.initials: MS
authors.lastname: Melikova
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology; D045744:Cell Line, Tumor / Q000166:cytology / Q000187:drug effects; D004705:Endocytosis / Q000502:physiology*; D011992:Endosomes / Q000378:metabolism; D066246:ErbB Receptors / Q000378:metabolism; D019084:Fluorescent Antibody Technique, Indirect; D006801:Humans; D008870:Microtubules / Q000502:physiology*; D015739:Nocodazole / Q000494:pharmacology
chemical_list: D000970:Antineoplastic Agents; D066246:ErbB Receptors; D015739:Nocodazole